WithdrawnPhase 4ketamine
Bubiket Study: Ultrasound Guided Fascia Iliaca Nerve Block With Bupivacaine and Adjuvant Ketamine vs. Bupivacaine Alone
Sponsored by Antonios Likourezos
NCT ID
NCT03909594
Start Date
2022-01-01
Est. Completion
2023-12-31
About This Study
The project is meant to evaluate the effect of a combination of medications (Bupivacaine + Ketamine) used in an ultra-sound guided nerve block for patients presenting to the Emergency Department (ED) with hip and/or femur fractures. The goal is to see whether the combination of these two medications will result in greater and longer-lasting pain relief, longer-lasting motor and sensory block and overall less need for opioid rescue analgesia.
Conditions Studied
Interventions
- •Bupivacaine
- •Ketamine
Eligibility
Age:18 Years - 120 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * 18 years and older * Presenting with isolated hip or femur fracture confirmed on x-ray. Exclusion Criteria: * Polytrauma * Unstable vitals signs * Allergy to Bupivacaine or Ketamine * Inability to give consent * Altered mental status * Greater than 100kg * Known end stage renal disease or hepatic dysfunction * Received \> 2 doses of Morphine in ER prior to regional nerve block * Patients with failed nerve block (30 minute onset)
Study Locations (1)
Maimonides Medical Center
Brooklyn, New York, United States